# Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors

Study · id `cardio:ct-nct04191330` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04191330](<https://clinicaltrials.gov/study/NCT04191330>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04191330

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 122 participants.

## Technical summary

Registry record NCT04191330. Randomized; no masking; primary purpose treatment. Start 2020-01-27 (actual); primary completion 2024-06-14 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 122 participants (enrolled count; ClinicalTrials.gov record NCT04191330, source copy `cardio:ctgov-nct04191330-2024-06-17`, retrieved 2026-10-26)
- Started: 2020-01-27 (actual) (ClinicalTrials.gov record NCT04191330, source copy `cardio:ctgov-nct04191330-2024-06-17`, retrieved 2026-10-26)
- Primary completion: 2024-06-14 (actual) (ClinicalTrials.gov record NCT04191330, source copy `cardio:ctgov-nct04191330-2024-06-17`, retrieved 2026-10-26)
- Completion: 2024-08-31 (anticipated) (ClinicalTrials.gov record NCT04191330, source copy `cardio:ctgov-nct04191330-2024-06-17`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04191330, source copy `cardio:ctgov-nct04191330-2024-06-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04191330-2024-06-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors
- Acronym: AIM-POWER
- Condition: Heart Failure
- Intervention (Device): BiovitalsHF
- Lead sponsor: Biofourmis Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Digital Platform to Optimize Guideline-Directed Heart Failure Therapy: Results of the AIM-POWER Trial (`cardio:pubmed-41332416`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: cd3b01583ae42d0dac4909a413d6edf77a5eff8d33154ae54b4c9e5cab5e325c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
